RAP 3.57% 14.5¢ resapp health limited

Delusional, page-3

  1. 1 Posts.
    The first Smartcough-C trial successfully diagnosed Bronchiolitis, while not exactly Bronchitis, it demonstrated the app could successfully diagnose a respiratory condition when the sound recordings were not compromised.

    While we appreciate your comment maybe take some time to do your own research before providing advice to others or blaming people. Everyone on here is responsible for their own investment decisions.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.